decisionhealth Newsletters, Coder Pink Sheets - 2010 Issue 6 (June)
New rules allow e-prescribing of common pain medications
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a DEA update affecting electronic prescribing of controlled substances in pain management and related practices. It covers the general purpose of the rule change, the kinds of compliance steps practices may need to consider, the role of approved third parties and vendors, and the importance of checking state law requirements. It is aimed at physicians, pain practices, and billing or compliance staff who need a high-level understanding of e-prescribing policy changes.
Why This Topic Matters
The rule change affects how practices prescribe certain medications, manage workflow, and maintain compliance with federal and state requirements. It is relevant to offices evaluating electronic prescribing systems, credentialing processes, and internal controls.
What You Will Learn
- The general purpose of the DEA rule change affecting electronic prescribing.
- The broad compliance areas practices may need to address for controlled-substance e-prescribing.
- The types of organizations involved in identity proofing and vendor approval.
- Why state requirements still matter alongside federal rules.
Who Should Read This
- Pain management practices
- Physicians
- Practice administrators
- Billing and compliance staff
- Healthcare operations teams
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com